跳至主要内容
临床试验/NCT05314855
NCT05314855
已完成
不适用

Role of the Central Brain Clock in the Pathophysiology of Insulin Resistance

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2 个研究点 分布在 1 个国家目标入组 28 人2023年1月4日

概览

阶段
不适用
干预措施
functional MRI
疾病 / 适应症
Insulin Resistance
发起方
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
入组人数
28
试验地点
2
主要终点
SCN blood oxygen level dependent (BOLD) response to light: mean SCN activity
状态
已完成
最后更新
3个月前

概览

简要总结

In this observational cohort study the investigators will determine the activity rhythm of the suprachiasmatic nucleus in humans with progressive stages of insulin resistance, using advanced functional brain imaging (7 Tesla functional MRI).

详细描述

Type 2 diabetes mellitus (T2DM) has an increasing worldwide incidence. Insulin resistance is a key pathophysiological process in the development of hyperglycemia in patients with T2DM. Disruption of circadian synchrony leads to insulin resistance. Animal studies and post-mortem human brain studies suggest that the master brain clock in the hypothalamic suprachiasmatic nucleus (SCN) plays a role in the development of insulin resistance. Up to now, no-one has investigated whether the in vivo activity rhythm of the SCN is affected in patients with insulin resistance. The investigators hypothesize that the master brain clock has an important role in the development of human insulin resistance.

注册库
clinicaltrials.gov
开始日期
2023年1月4日
结束日期
2025年11月1日
最后更新
3个月前
研究类型
Observational
性别
All

研究者

责任方
Principal Investigator
主要研究者

Dirk Jan Stenvers

Principal Investigator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

入排标准

入选标准

  • Group 1: obese people with normal insulin sensitivity
  • age 25-65 years
  • fasting plasma insulin ≤62 pmol/L
  • fasting plasma glucose \<5.6 mmol/L
  • Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) ≤ 4.5
  • Group 2: obese people with insulin resistance
  • age 25-65 years
  • fasting plasma insulin \>62 pmol/L
  • not fulfilling the American Diabetes Association (ADA) criteria for type 2 DM
  • Group 3: obese subjects with overt type 2 DM

排除标准

  • An extreme chronotype (midpoint of sleep on free days (MSFsc) before 2:00 or after 6:00).
  • Active psychiatric disorder (including circadian rhythm sleep disorder) as defined in Diagnostic and Statistical Manual of Mental Disorders (DSM) 5
  • Disorders of the central nervous system (Early-onset dementia, stroke, epilepsy, Parkinson's disease, brain tumor)
  • Severe visual impairment (WHO classification)
  • Shift workers
  • Crossing \> 2 time zones in the 3 months before the study
  • Patients with type 2 DM receiving insulin treatment or glucagon-like peptide (GLP) 1 agonists
  • MRI contraindications

研究组 & 干预措施

Obese individuals with normal insulin sensitivity

干预措施: functional MRI

Obese individuals with impaired insulin sensitivity

干预措施: functional MRI

Obese patients with type 2 diabetes

干预措施: functional MRI

结局指标

主要结局

SCN blood oxygen level dependent (BOLD) response to light: mean SCN activity

时间窗: mean activity over 24 hours

SCN BOLD response to light stimulus (percent BOLD signal change)

SCN BOLD response to light: time point of peak SCN activity

时间窗: 24 hours

time point (zeitgeber time in hh:mm)

SCN BOLD) response to light: time point of trough SCN activity

时间窗: 24 hours

time point (zeitgeber time in hh:mm)

Amplitude of SCN activity rhythm (peak-trough change in SCN activity)

时间窗: 24 hours

Peak-trough difference in SCN activity (percent BOLD signal change)

研究点 (2)

Loading locations...

相似试验